What is the recommended treatment for sinusitis, including acute bacterial and chronic cases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Sinusitis

Acute Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults, providing 90-92% predicted clinical efficacy against the major causative pathogens. 1

Confirming the Diagnosis Before Prescribing Antibiotics

Before initiating antibiotics, confirm that the patient meets at least one of the following criteria for acute bacterial rhinosinusitis (ABRS), as 98-99.5% of acute rhinosinusitis cases are viral and resolve spontaneously within 7-10 days 1:

  • Persistent symptoms ≥10 days without improvement (purulent nasal discharge with nasal obstruction or facial pain/pressure) 1
  • Severe symptoms for ≥3-4 consecutive days (fever ≥39°C with purulent nasal discharge and facial pain) 1
  • "Double sickening" – worsening symptoms after initial improvement from a viral upper respiratory infection 1

First-Line Antibiotic Selection

  • Standard regimen: Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days (or until symptom-free for 7 days, typically 10-14 days total) 1
  • High-dose regimen: Use amoxicillin-clavulanate 2 g/125 mg twice daily for patients with recent antibiotic use within the past month, age >65 years, moderate-to-severe symptoms, comorbid conditions, or immunocompromised state 1
  • Recent evidence supports shorter 5-7 day courses with comparable efficacy and fewer adverse effects 1

Alternatives for Penicillin Allergy

  • Non-severe (non-Type I) penicillin allergy: Second- or third-generation cephalosporins (cefuroxime, cefpodoxime, cefdinir, or cefprozil) for 10 days, as cross-reactivity is negligible 1
  • Severe (Type I/anaphylactic) penicillin allergy: Respiratory fluoroquinolones—levofloxacin 500 mg once daily for 10-14 days or moxifloxacin 400 mg once daily for 10 days 1
  • Doxycycline 100 mg once daily for 10 days is an acceptable but suboptimal alternative with 77-81% predicted efficacy (compared to 90-92% for first-line agents), reserved for penicillin-allergic patients when cephalosporins are contraindicated 1

Antibiotics to Avoid

  • Azithromycin and other macrolides should not be used due to resistance rates of 20-25% for both Streptococcus pneumoniae and Haemophilus influenzae 1
  • Trimethoprim-sulfamethoxazole has 50% resistance for S. pneumoniae and 27% for H. influenzae 1
  • First-generation cephalosporins (cephalexin) provide inadequate coverage against H. influenzae, as nearly 50% of strains are β-lactamase producing 1

Watchful Waiting Strategy

For adults with uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is an appropriate initial strategy when reliable follow-up can be assured. 1 Start antibiotics only if no improvement occurs by day 7 or if symptoms worsen at any time 1. The number needed to treat with antibiotics is 10-15 to achieve one additional cure over 7-15 days, reflecting the high rate of spontaneous recovery 1.

Essential Adjunctive Therapies (Add to All Patients)

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and improve symptom resolution, supported by strong evidence from multiple randomized controlled trials 2, 1
  • Saline nasal irrigation 2-3 times daily provides symptomatic relief and aids mucus clearance 2, 1
  • Analgesics (acetaminophen or ibuprofen) for pain and fever control 2, 1
  • Decongestants (oral or topical) may provide symptomatic relief; limit topical agents to ≤3 days to avoid rebound congestion 2, 3

Monitoring and Treatment Failure Protocol

  • Reassess at 3-5 days: If no improvement, switch to high-dose amoxicillin-clavulanate (2 g/125 mg twice daily) or a respiratory fluoroquinolone 1
  • Reassess at 7 days: If symptoms persist or worsen, reconfirm the diagnosis, exclude complications (orbital cellulitis, meningitis, brain abscess), and consider imaging or ENT referral 1
  • Worsening at any time requires immediate evaluation for complications and switching antibiotics 1

Pediatric Dosing

  • Standard-dose amoxicillin: 45 mg/kg/day divided into 2 doses for uncomplicated disease 1
  • High-dose amoxicillin: 80-90 mg/kg/day divided into 2 doses for children <2 years, in daycare, with recent antibiotic use, or in areas with high resistance 1
  • High-dose amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate divided into 2 doses for high-risk children 1
  • Treatment duration: Minimum 10-14 days for children (longer than adult courses) 1
  • Reassess at 72 hours: If no improvement or worsening, switch to high-dose amoxicillin-clavulanate 1

Common Pitfalls to Avoid

  • Do not prescribe antibiotics for symptoms lasting <10 days unless severe features are present (fever ≥39°C with purulent discharge for ≥3 consecutive days) 1
  • Do not obtain routine imaging (X-ray or CT) for uncomplicated acute bacterial sinusitis; reserve imaging for suspected complications or alternative diagnoses 1
  • Do not use fluoroquinolones as first-line therapy in patients without documented β-lactam allergies to prevent resistance development 1
  • Ensure adequate treatment duration (minimum 5 days for adults, 10 days for children) to prevent relapse 1

Chronic Sinusitis

Intranasal corticosteroids are the cornerstone of treatment for chronic sinusitis, defined as symptoms persisting ≥8 weeks, due to their anti-inflammatory effects and documented efficacy in relieving nasal congestion. 4

First-Line Therapy

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily are the primary treatment for chronic sinusitis 4
  • High-volume saline irrigation (hypertonic saline) prevents crusting of secretions and facilitates mechanical removal of mucus, potentially improving mucociliary clearance more effectively than normal saline 4

Role of Antibiotics in Chronic Sinusitis

  • For chronic infectious sinusitis, longer duration of antibiotic therapy (often >3 weeks) may be required, with attention to anaerobic pathogens 2, 4, 5, 6
  • Antibiotics play a controversial role in non-infectious chronic sinusitis and should not be the primary treatment 4
  • Chronic hyperplastic eosinophilic rhinosinusitis does not respond to antibiotics and requires systemic corticosteroids 2

Adjunctive Therapies

  • Decongestants may provide symptomatic relief by widening ostia and reducing turbinate swelling, but should be used cautiously due to potential systemic effects 4, 3
  • Antihistamines are beneficial for patients with an allergic rhinitis component 4
  • Mucolytics and expectorants may provide symptomatic benefit in selected cases 4

Evaluation for Underlying Conditions

  • Patients with chronic or recurrent sinusitis (≥3 episodes per year) should be evaluated for allergic rhinitis, gastroesophageal reflux disease (GERD), immunodeficiency, and anatomic abnormalities 2, 4
  • Tests for immunodeficiency (quantitative immunoglobulin measurement, functional antibody tests, HIV testing) should be considered in cases of recurrent sinusitis 2
  • Quantitative sweat chloride tests and genetic testing for cystic fibrosis should be considered in children with nasal polyps or colonization with Pseudomonas species 2

Surgical Intervention

  • Medically resistant sinusitis may respond to functional endoscopic sinus surgery, particularly in cases of localized persistent disease within the ostiomeatal complex 2

When to Refer to a Specialist

  • Specialist referral is indicated when sinusitis is refractory to two courses of appropriate antibiotics, recurrent (≥3 episodes per year), or significantly affects quality of life 4
  • Consultation should be sought when there is a need to clarify the allergic or immunologic basis for sinusitis 2, 4
  • Refer for suspected complications (orbital cellulitis, meningitis, intracranial abscess) or when imaging shows anatomic abnormalities requiring surgical correction 2

Critical Pitfalls

  • Overuse of antibiotics should be avoided unless there is clear evidence of bacterial infection 4
  • Chronic sinusitis should be considered a chronic inflammatory condition rather than a bacterial infection, so routine antibiotic therapy should be avoided 7
  • Empiric antibiotic therapy should be prescribed only when acute exacerbation of chronic sinusitis occurs, targeting the usual bacteria causing acute sinusitis 7

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nasal decongestants.

Drugs, 1981

Guideline

Management of Chronic Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Microbiology of chronic rhinosinusitis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016

Research

Acute and chronic bacterial sinusitis.

Infectious disease clinics of North America, 2007

Research

Bacterial colonization or infection in chronic sinusitis.

Wiener klinische Wochenschrift, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.